Specific immunotherapy effect on peripheral blood T1/T2 lymphocytes in atopic patients;Repercussão da imunoterapia espacifica na população T1 e T2 de linfócitos perféricos em doentes atópicos

Revista Portuguesa de Pneumologia

Volumn 12, Issue 2, 2006, Pages 107-130

  Rebordão, Manuela ^a   Delgado, Luis ^b   Pinto, Helena ^c   Remédios, Augusto ^c   Taborda Barata, L ^d  

^a Belém Military Hospital Analysis Clinic   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Belém Military Hospital   (Portugal)

^d UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

IL 10; Immunotherapy; Ratio IFN IL 4; T1 and T2 lymphocytes

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BREFELDIN A; BRONCHODILATING AGENT; CORTICOSTEROID; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; ATOPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; IMMUNOTHERAPY; MALE; NONPARAMETRIC TEST; PERIPHERAL LYMPHOCYTE; RANK SUM TEST; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 33745672271     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30428-1     Document Type: Article

References (35)

1. Lemanske R, Busse W. Asthma. J Allergy Clin Immunol 2003; 111: 5502-19.
2. Becky-kelly E, Busse W, Jarjour N. A comparison of the airway response to segmental antigen bronchoprovocation. in atopic asthma and allergic rhinitis. J Allergy Clin Immunol 2003; 111: 79-86.
3. Shi HZ, Deng JM, Xu H et al. Effect of inhaled interleukin-4 on airway hyperreactivity in asthmatics. Am J Respir Crit Care Med 1998; 157: 1818-1821.
4. Menzies-Gow A, Flood-Page P, Schmi K et al. Anti IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol 2003; 111: 714-9.
5. Krug N, Madden J, Redington A E et al. T - cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol 1996;14:319-326.
6. Albas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383 (6603): 787-93.
7. Maggi EP, Parronchi P, Manetti R, Simonelli C, Placcini M, Rugin FS, De Carli M, Rcci M, Romagnani S. Reciprocal regulatory effects of IFN-γ and IL4 on the in vitro development of human Th1 and Th2 clones. J Immunol 1992; 148: 2142-2148.
8. Freeman J. Further observation on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet 1911; 2: 814.
9. Neerven RJJ, Wikborg T, Lund G, Jacobsen B, Brinch - Nielsen A, Arnved J, Ipsen H. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum IgE facilitated allergen presentation. J Immunol 1999; 163: 2944-2952.
10. Akdis C, Blaser K. IL-10 induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J 1999; 13:603-609.
11. Levings M, Roncarolo MG. T- regulatory 1 cells: A novel subset of CD4+ T cells with immunoregulatory properties. J Allergy Clin Immunol 2000; 106: 5109-12.
12. Akdis CA, Blaser K. Mechanisms of allergen-specific immunotherapy. Allergy 2000; 55: 522-530.
13. Yang X. Does allergen inummotherapy alter the natural course of allergic disorders? Drugs 2001; 61 (3):366-374.
14. Durham S, Till S. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998; 102:157-64.
15. Gabrielsson S, Soderlund A, Paulie S, Kraan TCM, Blomberg M, Rak S. Specific immunotherapy prevents increased levels of allergen specific IL-4 and IL-13 producing cells during pollen season. Allergy 2001; 56: 293-300.
16. Jutel M, Pickler WJ, Skrbic D, Urmyler A, Dahindeu C and Meller U. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increased of IFN-g secretion in specific allergen-stimulated T cell cultures. The J of Immunol 1995; 154: 4187-4194.
17. Durham SR, Ying S, Varney VA et al. Grass pollen immunotherapy inhibits allergen-incluced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increase the number of cells expressing messenger RNA for IFN-γ. J Allergy Clin Immunol 1996; 97: 1356-65.
18. Tanaka A, Ohashi Y, Kakinoki Y and Nakai. Immunotherapy suppresses both Th1 and Th2 responses by allergen stimulation, but suppression of the Th2 response is a more important mechanism related to the clinical efficacy of immunotherapy for perennial allergic rhinitis. Scand J Immunol 1998; 48: 201-211.
19. Pene J, Desroches A, Paradis L et al. Immunotherapy with Fel d1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats. J Allergy Clin Immunol 1998; 102: 571-8.
20. Majori M, Caminati A, Corradi M, Briante E, Scarpa S, Pesci A. T-cell cytokine pattern at three time points during specific immunotherapy for mite - sensitive asthma. Clin Exp Allergy 2000; 30:341-47.
21. Jutel M, Akdis M, Budak F, Casaulta C, Wrzyszcz M, Bkaser K, Akdis C. IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Inummol 2003; 33: 1205-1214.
22. Picker LJ, Singh MK, Zdraveski Z et al. Direct demonstration of cytokine synthesis heterogeneity among human memory effector T cells by flow citometry. Blood. 1995; 86:1408-1419.
23. Pala P, Hussell T, Openshaw P. Flow cytometric measurement of intracellular cytokines. J Immunol Methods 2000; 243:107-124.
24. Bellinhausen J, Metz G, Enk A, Christmann S, Krop J, Salog J. Insect venom immunotherapy induces interleukin - 10 production and Th2 to Th1 shift and changes surface marker expression in venom - allergic subjects. Eur J Immunol 1997; 27: 1131-1139.
25. O'Brien RM, Xu H, Rolland JM, Byron KA, Thomas WR. Allergen-specific production of interferon-γ by peripheral blood mononuclear cells and CD8+ T cells in allergic disease and following immunotherapy. Clin Exp Allergy 2000; 30: 333-340.
26. Rebordão MM, Silva M, Remédios A, Alvares E, Pinto H, Alfarroba E. Estudo de citocinas de Linfócitos T e de Imunoglobulinas E e G em doentes atópicos cardidatos a imunoterapia. Rev Port Imunoalergologia 2003; XI (4):370-379.
27. Rebordão MM, Delgado L, Pinto HP, Remédios A, Taborda-Barata L. Citocinas T1 e T2 na doença atópica: avaliação do contributo relativo de diferentes subpopulações celulares T periféricas. Rev Port Imunoalergologia 2005 (a aguardar publicação).
28. Benjaponpitak S, Oro A, Maguire P et al. The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy. J Allergy Clin Immunol 1999; 103(3Pt 1):468-75.
29. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102:98-106.
30. Leon K, Peréz R, Lage A, Carneiro J. Modelling T-cell-mediated suppression dependent on interactions in multicellular conjugates. J Theor Biol 2000; 207:231-254.
31. Tanchot C, Guillaume S, Delon J, Bourgeois C, Franzke A, Sarukhan A, Trautmann A, Rocha B. Modifications of CD8+ T cell function during in vivo memory or tolerance induction. Immunity 1998; 8:581-590
32. Gillit M, Liu YJ.Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytold dendritic cells.J Exp Med 2002; 195(6):695-704.
33. Roches A, Paradis L, Menardo JL et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract:VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997; 99(4):450-3.
34. Moore KW, Malefyt RW, Coffman RL, O'Garra A. Interleukin-10 and the Interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765.
35. Becker JC, Czerny C, Brocker EV. Maintenance of clonal anergy by endogenously produced IL-10. International Immunol 1994; 6(10):1605-1612.